Antibodies Against Hypothalamus and Pituitary Gland in Childhood-Onset Brain Tumors and Pituitary Dysfunction
Conclusions: Brain tumors especially germinoma are associated with the development of hypothalamic–pituitary antibodies and pituitary defects. The correct interpretation of APA/AHA antibodies is essential to avoid a misdiagnosis of an autoimmune infundibulo-neurohypophysitis or pituitary hypophysitis in patients with germinoma.
Conditions: Lung Cancer; Non Small Cell Lung Cancer Intervention: Sponsors: Picomole Inc; University of California, Irvine Not yet recruiting
Conditions: Digestive System Neoplasms; Thoracic Neoplasms Interventions: Behavioral: Emotional skills; Behavioral: Short free talk and relaxation Sponsors: University Hospital, Lille; SCALab UMR CNRS 9193 Not yet recruiting
Conditions: Breast Cancer Metastatic; BRCA 1 Gene Mutation; BRCA 2 Gene Mutation Intervention: Drug: SC10914 Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd. Recruiting
Condition: MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer Intervention: Drug: AK104 Sponsor: Peking University Not yet recruiting
Conditions: Ovarian Neoplasms; Fallopian Tube Neoplasms; Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Adnexal Diseases; Genital Diseases, Female; Endocrine System Diseases; Gonadal Disorders; Carcinoma; Bevaci...
Condition: Metastatic Prostate Cancer Interventions: Behavioral: Exercise therapy + radiation therapy; Radiation: Radiation therapy Sponsor: Milton S. Hershey Medical Center Not yet recruiting
Condition: Breast Cancer Interventions: Behavioral: Postcard; Behavioral: Small Gift; Behavioral: Loss Frame and Fear Appeals Sponsor: Geisinger Clinic Not yet recruiting
Conditions: Head and Neck Squamous Cell Carcinoma; Malignant Solid Neoplasm Interventions: Drug: Alisertib; Biological: Pembrolizumab Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Recruiting
Condition: Prostate Cancer Interventions: Diagnostic Test: PSMA PET/CT guided intensification of therapy; Other: Control Arm Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Cancer Society Research Institute (CCSRI); Lantheus Medical Imaging; British Columbia Cancer Agency; London Health Sciences Centre; Princess Margaret Hospital, Canada; Tom Baker Cancer Centre; Mc Master University; Institute of Healt...
Conditions: Liposarcoma; CRC; Prostate Cancer; Breast Neoplasms; Adenocarcinoma of Lung; Solid Tumors Interventions: Drug: PF-07220060; Combination Product: Letrozole; Combination Product: Fulvestrant Sponsor: Pfizer Not yet recruiting